Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis

Frontiers in Cardiovascular Medicine

Weiqi Chen¹  Yimo Zhou¹  Yongjun Wang¹  Meng Lu² 

[1] Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;China National Clinical Research Center for Neurological Diseases, Beijing, China;Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China;Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China;Department of Pharmacy, National Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

关键词: proprotein convertase subtilisin/kexin type 9;    cardiovascular events;    stroke;    mortality;    association;   

DOI  :  10.3389/fcvm.2021.617249

来源: Frontiers

【 授权许可】

CC BY